Literature DB >> 25173210

Cardiac amyloidosis: a report of two cases.

Chandrashekhar Munjewar1, Rahul Agrawal2, Satyavan Sharma3.   

Abstract

Cardiac amyloidosis is a manifestation of multisystem disorder. The condition is rare, difficult to diagnose and invariably fatal. We report 2 cases of amyloidosis associated with plasma cell dyscrasia. A high index of clinical suspicion, echocardiographic clues (ventricular thickening, diastolic dysfunction, biatrial enlargement) and elevated cardiac biomarkers led to the diagnosis. Early institution of amyloid specific treatment should be the aim. Cardiac treatment is supportive and results are often disappointing.
Copyright © 2014 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac amyloidosis; Plasma cell dyscrasia; Waldenstrom's macroglobulinemia

Mesh:

Substances:

Year:  2014        PMID: 25173210      PMCID: PMC4150044          DOI: 10.1016/j.ihj.2014.05.028

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  8 in total

1.  Left ventricular torsion by two-dimensional speckle tracking echocardiography in patient with a-type amyloid heart disease.

Authors:  Can Yucel Karabay; Gonenc Kocabay
Journal:  J Am Soc Echocardiogr       Date:  2010-11-12       Impact factor: 5.251

Review 2.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

3.  Cardiac amyloidosis.

Authors:  C Cristina Quarta; Jenna L Kruger; Rodney H Falk
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

4.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 5.  Evaluation and management of the cardiac amyloidosis.

Authors:  Joseph B Selvanayagam; Philip N Hawkins; Biju Paul; Saul G Myerson; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

6.  M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

Authors:  A G Siqueira-Filho; C L Cunha; A J Tajik; J B Seward; T T Schattenberg; E R Giuliani
Journal:  Circulation       Date:  1981-01       Impact factor: 29.690

7.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Authors:  Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Philip R Greipp; Thomas E Witzig; John A Lust; S Vincent Rajkumar; Rafael Fonseca; Steven R Zeldenrust; Christopher G A McGregor; Allan S Jaffe
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

8.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

  8 in total
  1 in total

1.  Rare Complication of a Rare Malignancy: Case Report of Cardiac Amyloidosis Secondary to Waldenstrom Macroglobulinemia.

Authors:  Aaron Charles Lobo; Vivek Bhat; Seetharam Anandram; Shanthala Devi A M; Sanjukta S Rao; Ge-Vivin Vinister; Veronica Lobo; Cecil Reuben Ross
Journal:  Qatar Med J       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.